A comparison of the effects of ramipril and losartan on blood pressure control and left ventricle hypertrophy in patients with autosomal dominant polycystic kidney disease
- 19 August 2010
- journal article
- research article
- Published by Taylor & Francis Ltd in Renal Failure
- Vol. 32 (8), 913-917
- https://doi.org/10.3109/0886022x.2010.502277
Abstract
Hypertension is frequently seen in autosomal dominant polycystic kidney disease (ADPKD), and it has a negative effect on renal progression. Hypertension and left ventricle hypertrophy (LVH) are related in terms of pathogenesis and their effects on renal progression. In this study, we aimed to compare the effects of losartan and ramipril on blood pressure (BP) control, LVH, and renal progression in patients with hypertensive ADPKD. Thirty-two ADPKD patients with ages ranging between 18 and 70 years who were stage 1-2 hypertensive were included in this study. Routine biochemical tests and echocardiography were obtained at first examination of the patients. Following these, the patients were randomized. One group was given losartan and the other ramipril. They were followed up for 1 year, and their echocardiographies and routine biochemical tests were repeated at the end of the year. BP values decreased in both the groups at the end of the first year (p < 0.001). There was a statistically significant difference in LVH in both the groups at the end of the first year than at the beginning (losartan, p = 0.007; ramipril, p < 0.001). In this study, effective BP control was obtained with losartan and ramipril and LVH was found to be regressed significantly in the hypertensive patients with ADPKD. These two groups of antihypertensive drugs may also have beneficial effects on the retardation of renal progression and in reducing cardiovascular mortality in hypertensive patients with ADPKD.Keywords
This publication has 16 references indexed in Scilit:
- Biventricular diastolic dysfunction in patients with autosomal-dominant polycystic kidney diseaseKidney International, 2005
- Calcium Channel Blocker versus Angiotensin II Receptor Blocker in Autosomal Dominant Polycystic Kidney DiseaseNephron Clinical Practice, 2005
- Exercise blood pressure, cardiac structure, and diastolic function in young normotensive patients with polycystic kidney disease: A prehypertensive stateAmerican Journal of Kidney Diseases, 2004
- Polycystic Kidney DiseaseNew England Journal of Medicine, 2004
- Epidemiological study of kidney survival in autosomal dominant polycystic kidney diseaseKidney International, 2003
- Cardiac and Renal Effects of Standard Versus Rigorous Blood Pressure Control in Autosomal-Dominant Polycystic Kidney DiseaseJournal of the American Society of Nephrology, 2002
- Clinical, public health, and research implications of the Heart Outcomes Prevention Evaluation (HOPE) StudyEuropean Heart Journal, 2001
- Autosomal Dominant Polycystic Kidney DiseaseNew England Journal of Medicine, 1993
- Effects of angiotensin converting enzyme inhibition in adult polycystic kidney diseaseKidney International, 1992
- Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findingsThe American Journal of Cardiology, 1986